Research Output per year
Research Output
2020
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors
Garg, M., Royce, S. G. & Lubel, J. S., 6 May 2020, (Accepted/In press) In : Alimentary Pharmacology & Therapeutics. 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
File
1
Citation
(Scopus)
Renin–angiotensin–aldosterone system inhibitors in CoviD-19
Lubel, J. & Garg, M., 11 Jun 2020, In : New England Journal of Medicine. 382, 24, 3 p., e92.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
Survival of patients with ruptured and non-ruptured hepatocellular carcinoma
Tan, N. P., Majeed, A., Roberts, S. K., Gow, P. J., Hey, P., Mah, X., Goodwin, M., Sood, S., Lubel, J., Nicoll, A., Dev, A., Bell, S. J. & Kemp, W. W., Apr 2020, In : The Medical Journal of Australia. 212, 6, p. 277-278 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
File
The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis
Ardalan, Z. S., Sparrow, M. & Gibson, P. R., 1 Jul 2020, In : Gastroenterology. 159, 1, p. 359-400 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
2019
Dietary fat and the faecal microbiome: Where collinearity may lead to incorrect attribution of effects to fat
Ardalan, Z. S., Sparrow, M. P., Muir, J. G. & Gibson, P. R., Sep 2019, (Accepted/In press) In : Gut. 1 p.Research output: Contribution to journal › Letter › Other › peer-review
Efficacy of glutamine in postinfection IBS
Ford, A. C. & Gibson, P. R., 1 Oct 2019, In : Gut. 68, 10, p. 1905-1906 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' reply
Mitchell, H., Porter, J., Gibson, P. R., Barrett, J. & Garg, M., 1 Apr 2019, In : Alimentary Pharmacology & Therapeutics. 49, 8, p. 1109-1110 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
Prebiotics Versus Low FODMAP Diet: An Interpretative Nightmare
Varney, J., Muir, J. G. & Gibson, P. R., Mar 2019, In : Gastroenterology. 156, 4, p. 1222 1 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
Reply
Colombel, J. F., Shin, A. & Gibson, P. R., Feb 2019, In : Clinical Gastroenterology and Hepatology. 17, 3, p. 573-574 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
2018
Is Non-Celiac Rice-Starch Sensitivity as Common in Children as Non-Celiac Gluten Sensitivity?
Gibson, P. R., Lundin, K. E. A. & Guandalini, S., 1 Aug 2018, In : American Journal of Gastroenterology. 113, 8, 1 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
Letter: vedolizumab drug concentrations in neonates following intrauterine exposure
Flanagan, E., Gibson, P. R., Begun, J., Ghaly, S., Garg, M., Andrews, J. M., Rosella, O., Rosella, G. & Bell, S. J., 1 Dec 2018, In : Alimentary Pharmacology & Therapeutics. 48, 11-12, p. 1328-1330 3 p.Research output: Contribution to journal › Letter › Other › peer-review
3
Citations
(Scopus)
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply
Christensen, B., Gibson, P. R. & Rubin, D. T., May 2018, In : Alimentary Pharmacology & Therapeutics. 47, 10, p. 1423-1424 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
3
Citations
(Scopus)
Reply
Skodje, G. I., Henriksen, C., Veierød, M. B., Gibson, P. R. & Lundin, K. E. A., Jul 2018, In : Gastroenterology. 155, 1, 1 p.Research output: Contribution to journal › Letter › Other › peer-review
2017
Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right
Gibson, P. R., Halmos, E. P. & Muir, J. G., 1 Aug 2017, In : Alimentary Pharmacology & Therapeutics. 46, 3, p. 385-386 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
Letter: low-FODMAP diet for exercise-induced gastrointestinal syndrome—Authors’ reply
Da Costa, R. J., Snipe, R. M. J., Kitic, C. & Gibson, P. R., 1 Nov 2017, In : Alimentary Pharmacology & Therapeutics. 46, 10, p. 1023-1024 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
4
Citations
(Scopus)
New onset vitiligo following commencement of infliximab in Crohn disease
Luber, R. P., Chamberlain, A. J. & Sparrow, M. P., 1 Aug 2017, In : Internal Medicine Journal. 47, 8, p. 972-973 2 p.Research output: Contribution to journal › Letter › Other › peer-review
1
Citation
(Scopus)
Train-the-trainer education and colonoscopy quality indicators: Where to now?
Roberts, S. K., 1 Aug 2017, In : Gut. 66, 8, p. 1533-1534 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2016
Diet Therapy for Irritable Bowel Syndrome: Is a Diet Low in FODMAPS Really Similar in Efficacy to Traditional Dietary Advice?
Gibson, P. R., Varney, J. E. & Muir, J. G., 1 Apr 2016, In : Gastroenterology. 150, 4, p. 1046-1047 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
Supersonic Shear Imaging and Transient Elastography in Obesity
Thwaites, P. A., Roberts, S. K., Kitson, M. & Kemp, W., 1 Mar 2016, In : Clinical Gastroenterology and Hepatology. 14, 3, p. 484 1 p.Research output: Contribution to journal › Letter › Other › peer-review
1
Citation
(Scopus)
2015
Association between reduced plasma 25-hydroxyvitamin D and increased risk of cancer in patients with inflammatory bowel disease
Kitson, M. T., Garg, M. & Roberts, S. K., 1 Apr 2015, In : Clinical Gastroenterology and Hepatology. 13, 4, p. 813-814 2 p.Research output: Contribution to journal › Letter › Other › peer-review
1
Citation
(Scopus)
Editorial: a new shift in the paradigm of treatment for the irritable bowel syndrome?
Peters, S. L. & Gibson, P. R., 2015, In : Alimentary Pharmacology & Therapeutics. 41, 12, p. 1296 - 1296 1 p.Research output: Contribution to journal › Letter › Other
Relationship between vitamin D status and response to hepatitis C virus therapy
Kitson, M. T., Sarrazin, C., Toniutto, P. & Roberts, S. K., 1 Nov 2015, In : Hepatology. 62, 5, p. 1642-1643 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
Reply to: "evidence supporting a beneficial role of Vitamin D in chronic hepatitis C"
Kitson, M. T., Sarrazin, C., Toniutto, P. & Roberts, S. K., 2015, In : Journal of Hepatology. 63, 2, p. 531-532 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2014
Editorial: Noncoeliac gluten sensitivity - A disease of the mind or gut? Authors' reply
Peters, S. L., Biesiekierski, J. R., Yelland, G. W., Muir, J. G. & Gibson, P. R., 2014, In : Alimentary Pharmacology & Therapeutics. 40, 1, p. 114-115 2 p.Research output: Contribution to journal › Letter › Other › peer-review
1
Citation
(Scopus)
Editorial: `Brain Fog' and coeliac disease - evidence for its existence: authors' reply
Lichtwark, I. T., Newnham, E., Robinson, S. R., Gibson, P. R. & Yelland, G. W., 2014, In : Alimentary Pharmacology & Therapeutics. 40, 5, p. 566 - 566 1 p.Research output: Contribution to journal › Letter › Other
Open source clinical science for emerging infections
Dunning, J. W., Merson, L., Rohde, G. G. U., Gao, Z., Semple, M. G., Tran, D., Gordon, A., Olliaro, P. L., Khoo, S. H., Bruzzone, R., Horby, P., Cobb, J. P., Longuere, K. S., Kellam, P., Nichol, A., Brett, S., Everett, D. B., Walsh, T. S., Hien, T. T. M., Yu, H. & 14 others, , Jan 2014, In : Lancet Infectious Diseases. 14, 1, p. 8-9 2 p.Research output: Contribution to journal › Letter › Other › peer-review
22
Citations
(Scopus)
Reply
Halmos, E. P., Muir, J. G. & Gibson, P. R., 2014, In : Gastroenterology. 146, 7, p. 1830-1831 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
2013
Commentary: Sugar intolerances in functional gastrointestinal disorders
Barrett, J. S. & Gibson, P. R., 2013, In : Alimentary Pharmacology & Therapeutics. 38, 1, p. 72 - 72 1 p.Research output: Contribution to journal › Letter › Other
1
Citation
(Scopus)
Not all effects of a gluten-free diet are due to removal of gluten
Gibson, P. R. & Muir, J. G., 2013, In : Gastroenterology. 145, 3, p. 693 - 693 1 p.Research output: Contribution to journal › Letter › Other
14
Citations
(Scopus)
Pathogenesis of colonic diverticulosis: repainting the picture
Burgell, R., Muir, J. G. & Gibson, P. R., 2013, In : Clinical Gastroenterology and Hepatology. 11, 12, p. 1628 - 1630 3 p.Research output: Contribution to journal › Letter › Other
7
Citations
(Scopus)
Reply to: "vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection"
Kitson, M. T., Button, P. & Roberts, S. K., Jul 2013, In : Journal of Hepatology. 59, 1, p. 194-195 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
File
2
Citations
(Scopus)
The low FODMAP diet for treatment of irritable bowel syndrome and other gastrointestinal disorders
Muir, J. G. & Gibson, P. R., 2013, In : Gastroenterology and Hepatology. 9, 7, p. 450 - 452 3 p.Research output: Contribution to journal › Letter › Other
25
Citations
(Scopus)
2012
Feasibility and performance of the FibroScan XL probe
Kemp, W. & Roberts, S., Apr 2012, In : Hepatology. 55, 4, p. 1308-1309 2 p.Research output: Contribution to journal › Letter › Other › peer-review
5
Citations
(Scopus)
Why thiopurine metabolites are relevant
Friedman, A. B., Sparrow, M. P. & Gibson, P. R., Feb 2012, In : Alimentary Pharmacology & Therapeutics. 35, 3, p. 400-401 2 p.Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)
2011
Reply
Sievert, W., Dore, G. J. & Roberts, S. K., May 2011, In : Hepatology. 53, 5, p. 1775-1776 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Response to Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2011 [Epub ahead of print].
Friedman, A. B. & Sparrow, M. P., Dec 2011, In : Inflammatory Bowel Diseases. 17, 12Research output: Contribution to journal › Letter › Other › peer-review
2009
Author response
Barrett, J. S., Shepherd, S. J. & Gibson, P. R., Nov 2009, In : Journal of Parenteral and Enteral Nutrition. 33, 6, p. 733-734 2 p.Research output: Contribution to journal › Letter › Other › peer-review